Leandro João, Saraste Jaakko, Leandro Paula, Flatmark Torgeir
Department of Biomedicine University of Bergen Norway; Metabolism and Genetics Group Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL) Faculty of Pharmacy University of Lisbon Portugal.
Department of Biomedicine University of Bergen Norway.
FEBS Open Bio. 2017 Jan 21;7(2):195-203. doi: 10.1002/2211-5463.12175. eCollection 2017 Feb.
Mammalian phenylalanine hydroxylase (PAH) has a potential allosteric regulatory binding site for l-phenylalanine (l-Phe), in addition to its catalytic site. This arrangement is supported by a crystal structure of a homodimeric truncated form of the regulatory domain of human PAH (hPAH-RD ) [Patel D . (2016) doi: 10.1038/srep23748]. In this study, a fusion protein of the domain (MBP-(pep)-hPAH-RD ) was overexpressed and recovered in a metastable and soluble state, which allowed the isolation of a dimeric and a monomeric fusion protein. When cleaved from MBP, hPAH-RD forms aggregates which are stereospecifically inhibited by l-Phe (> 95%) at low physiological concentrations. Aggregation of the cleaved dimer of the mutant form hPAH-G46S-RD was not inhibited by l-Phe, which is compatible with structurally/conformationally changed βαββαβ ACT domain folds in the mutant.
除了催化位点外,哺乳动物苯丙氨酸羟化酶(PAH)还有一个潜在的L-苯丙氨酸(L-Phe)变构调节结合位点。人PAH调节域(hPAH-RD)的同二聚体截短形式的晶体结构支持了这种结构安排[帕特尔D.(2016年)doi:10.1038/srep23748]。在本研究中,该结构域的融合蛋白(MBP-(pep)-hPAH-RD)以亚稳态和可溶状态过表达并回收,这使得能够分离出二聚体和单体融合蛋白。当从MBP切割下来时,hPAH-RD会形成聚集体,在低生理浓度下,L-Phe(>95%)对其有立体特异性抑制作用。突变形式hPAH-G46S-RD的切割二聚体的聚集不受L-Phe抑制,这与突变体中结构/构象改变的βαββαβ ACT结构域折叠相一致。